Annual Total Assets
$370.02 M
+$63.24 M+20.62%
31 December 2023
Summary:
Keros Therapeutics annual total assets is currently $370.02 million, with the most recent change of +$63.24 million (+20.62%) on 31 December 2023. During the last 3 years, it has risen by +$100.58 million (+37.33%). KROS annual total assets is now at all-time high.KROS Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$579.27 M
+$124.25 M+27.31%
30 September 2024
Summary:
Keros Therapeutics quarterly total assets is currently $579.27 million, with the most recent change of +$124.25 million (+27.31%) on 30 September 2024. Over the past year, it has increased by +$253.02 million (+77.56%). KROS quarterly total assets is now at all-time high.KROS Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.6% | +77.6% |
| 3 y3 years | +37.3% | +151.9% |
| 5 y5 years | +1249.9% | - |
KROS Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.0% | at high | +155.6% |
| 5 y | 5 years | at high | +3277.7% | at high | +5187.7% |
| alltime | all time | at high | +3277.7% | at high | +5187.7% |
Keros Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $579.27 M(+27.3%) |
| June 2024 | - | $455.02 M(-6.3%) |
| Mar 2024 | - | $485.82 M(+31.3%) |
| Dec 2023 | $370.02 M(+20.6%) | $370.02 M(+13.4%) |
| Sept 2023 | - | $326.25 M(-8.4%) |
| June 2023 | - | $356.31 M(-7.3%) |
| Mar 2023 | - | $384.44 M(+25.3%) |
| Dec 2022 | $306.78 M | $306.78 M(+21.5%) |
| Sept 2022 | - | $252.55 M(+11.4%) |
| June 2022 | - | $226.66 M(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $235.14 M(-7.9%) |
| Dec 2021 | $255.25 M(-5.3%) | $255.25 M(+11.0%) |
| Sept 2021 | - | $229.96 M(-5.5%) |
| June 2021 | - | $243.46 M(-5.5%) |
| Mar 2021 | - | $257.73 M(-4.3%) |
| Dec 2020 | $269.44 M(+2359.5%) | $269.44 M(+94.9%) |
| Sept 2020 | - | $138.25 M(-8.1%) |
| June 2020 | - | $150.44 M(+148.3%) |
| Mar 2020 | - | $60.59 M(+453.1%) |
| Dec 2019 | $10.96 M(-60.0%) | $10.96 M |
| Dec 2018 | $27.41 M | - |
FAQ
- What is Keros Therapeutics annual total assets?
- What is the all time high annual total assets for Keros Therapeutics?
- What is Keros Therapeutics annual total assets year-on-year change?
- What is Keros Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Keros Therapeutics?
- What is Keros Therapeutics quarterly total assets year-on-year change?
What is Keros Therapeutics annual total assets?
The current annual total assets of KROS is $370.02 M
What is the all time high annual total assets for Keros Therapeutics?
Keros Therapeutics all-time high annual total assets is $370.02 M
What is Keros Therapeutics annual total assets year-on-year change?
Over the past year, KROS annual total assets has changed by +$63.24 M (+20.62%)
What is Keros Therapeutics quarterly total assets?
The current quarterly total assets of KROS is $579.27 M
What is the all time high quarterly total assets for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total assets is $579.27 M
What is Keros Therapeutics quarterly total assets year-on-year change?
Over the past year, KROS quarterly total assets has changed by +$253.02 M (+77.56%)